Cardiology – Medxy AI

Addressing Under-Detection of Sleep Apnea in Black Individuals: The Role of Racial Differences in Oxygen Desaturation and Heart-Rate Response

By MedXY 11/11/2026

This article examines how pulse oximetry may under-detect sleep apnea events in Black individuals due to skin pigmentation-related measurement bias, highlighting heart-rate response as a reliable, pigmentation-independent marker predictive of cardiovascular risk.

Cardiology Clinical Updates

Simplifying Access Site Closure in Transfemoral TAVR: Insights from the SINGLE-CLOSURE Trial

By MedXY 11/11/2026

The SINGLE-CLOSURE trial demonstrated that single-ProGlide closure is noninferior to double-ProGlide closure in reducing vascular complications after transfemoral TAVR, offering a simpler alternative without increased risk.

Plozasiran：一种可显著降低严重高甘油三酯血症及胰腺炎风险的新型 siRNA 疗法

Cardiology Clinical Updates Gastroenterology

Plozasiran: A Novel siRNA Therapy Reducing Severe Hypertriglyceridemia and Pancreatitis Risk

By MedXY 11/11/2026

Plozasiran, targeting APOC3 mRNA, significantly lowers triglyceride levels and reduces acute pancreatitis incidence in severe hypertriglyceridemia patients, according to pooled data from two placebo-controlled trials.

左主干冠状动脉病变中：药物洗脱支架 PCI 与 CABG 的长期结局比较——来自 IRIS-MAIN 登记研究的启示

Cardiology Clinical Updates

Long-term Comparative Outcomes of PCI with Drug-Eluting Stents Versus CABG in Left Main Coronary Artery Disease: Insights from the IRIS-MAIN Registry

By MedXY 11/10/2026

A decade-long multicentre Asian registry analysis revealed no significant difference in all-cause mortality between PCI with drug-eluting stents and CABG for unprotected left main coronary artery disease, highlighting the need for individualized Heart Team-based decision-making.

评估 PREVENT-HF 风险方程：在多样化队列中预测 HFpEF 与 HFrEF 的差异化准确性

Cardiology Clinical Updates

Assessing the PREVENT-HF Risk Equations: Differential Accuracy in Predicting HFpEF versus HFrEF Across Diverse Cohorts

By MedXY 11/10/2026

The PREVENT-HF equations demonstrate excellent capability in predicting 10-year risk of heart failure, particularly for HFpEF, across diverse community and clinical samples, highlighting opportunities for subtype-specific risk stratification.

Cardiology Clinical Updates

Coronary CT Angiography versus Intravascular Ultrasound Guidance for PCI: A Landmark Noninferiority Study

By MedXY 11/10/2026

A pivotal trial demonstrates that coronary CT angiography-guided PCI is noninferior to intravascular ultrasound-guided PCI in reducing target-vessel failure at 12 months, expanding options for personalized coronary intervention guidance.

Vutrisiran在转甲状腺素蛋白淀粉样变性心肌病中的持续获益：HELIOS-B开放标签延长期研究启示

Cardiology Clinical Updates

Sustained Benefits of Vutrisiran in Transthyretin Amyloidosis-Associated Cardiomyopathy: Insights From the HELIOS-B Open-Label Extension

By MedXY 11/09/2026

Long-term treatment with vutrisiran provides sustained improvements in mortality, cardiovascular events, cardiac biomarkers, functional capacity, and quality of life in patients with transthyretin amyloidosis cardiomyopathy, emphasizing the value of early intervention.

Cardiology Clinical Updates

Transcatheter Aortic Valve Replacement in Moderate Aortic Stenosis Patients with At-Risk Features: A Paradigm Shift in Management

By MedXY 11/09/2026

TAVR significantly reduces death and heart failure events compared to clinical surveillance in patients with moderate aortic stenosis exhibiting at-risk features, marking a potential new therapeutic approach.

Cardiology Clinical Updates OB/GYN & Women's Health

Influence of Cardiometabolic Status on Cardiovascular Effects of Oral Menopausal Hormone Therapy

By MedXY 11/08/2026

This review synthesizes evidence from randomized trials indicating that baseline lipid profiles significantly modify coronary heart disease risk associated with oral menopausal hormone therapy, underscoring the importance of lipid assessment for personalized therapy.

靶向心血管风险相关炎症：口服 NLRP3 抑制剂 Ruvonoflast 的疗效与安全性

Cardiology Clinical Updates Diabetes & Endocrinology

Targeting Inflammation in Cardiovascular Risk: Efficacy and Safety of Oral NLRP3 Inhibitor Ruvonoflast

By MedXY 11/08/2026

This Phase 1b trial demonstrates that oral NLRP3 inhibition with ruvonoflast markedly reduces systemic inflammatory biomarkers in obese individuals at elevated cardiovascular risk, with favorable safety and tolerability, supporting further clinical development.

Cardiology Clinical Updates

Transcatheter Aortic Valve Replacement in Severe Pure Aortic Regurgitation: Insights from the SEASON-AR Randomized Trial

By MedXY 11/07/2026

This article reviews the SEASON-AR trial demonstrating that TAVR plus medical therapy significantly reduces death, disabling stroke, and heart failure rehospitalization at one year compared to medical therapy alone in high-risk patients with severe pure aortic regurgitation.

Cardiology Clinical Updates Respiratory

Unlocking the Variability in Cardiopulmonary Exercise Testing: Impact of Prediction Equations on Exercise Capacity Classification

By MedXY 11/07/2026

Different cardiopulmonary exercise testing prediction equations yield widely variable percent-predicted values for peak oxygen uptake, leading to frequent reclassification of exercise performance influenced mainly by body mass index, age, and sex.

Cardiology Clinical Updates OB/GYN & Women's Health

Decoding Anti-Müllerian Hormone Trajectories During Menopause: Implications for Cardiovascular Health

By MedXY 11/06/2026

Analysis of anti-müllerian hormone (AMH) trajectories reveals two distinct decline patterns across menopause, with slower AMH decline linked to higher postmenopausal cardiovascular risk, independent of premenopausal risk factors.

Cardiology Clinical Updates OB/GYN & Women's Health

Integrated Resistance Training, Aerobic Exercise, and Sedentary Behavior Reduction Significantly Lower Cardiovascular Risk in U.S. Women

By MedXY 11/06/2026

Consistent resistance training combined with recommended aerobic activity and low sedentary television viewing substantially reduces major cardiovascular events risk in women, particularly myocardial infarction.

Cardiology Clinical Updates Emergency Medicine

Evaluating Immediate Ambulatory ECG Monitoring for Unexplained Syncope: Insights from the ASPIRED Trial

By MedXY 11/06/2026

The ASPIRED trial showed that 14-day ambulatory ECG monitoring after unexplained syncope in the emergency department did not significantly reduce syncope recurrence compared to standard care over one year.

联合评估 LDL-C、Lp(a) 和 hsCRP：多民族人群心血管风险预测更精准

Cardiology Clinical Updates

Enhanced Cardiovascular Risk Prediction Through Combined LDL-C, Lp(a), and hsCRP Assessment in a Multiethnic Population

By MedXY 11/05/2026

Combined measurement of LDL-C, lipoprotein(a), and hsCRP improves long-term prediction of atherosclerotic cardiovascular disease in a multiethnic cohort, highlighting important ethnic differences in absolute ASCVD risk.

GLP-1受体激动剂在心脏移植后糖尿病管理中的疗效与安全性：来自西班牙多中心研究的启示

Cardiology Clinical Updates Diabetes & Endocrinology

Efficacy and Safety of GLP-1 Receptor Agonists in Managing Post-Transplant Diabetes Among Heart Transplant Patients: Insights from a Multicenter Spanish Study

By MedXY 11/04/2026

This multicenter retrospective study shows that GLP-1 receptor agonists improve glycemic control and cardiometabolic parameters with good tolerance in heart transplant recipients with type 2 diabetes, supporting their therapeutic role in this high-risk population.

Cardiology Clinical Updates Internal Medicine

Anticoagulation in Octogenarians with Atrial Fibrillation: Balancing Mortality Benefits and Bleeding Risks

By MedXY 11/04/2026

Anticoagulation therapy in adults aged 80 and older with atrial fibrillation is linked to reduced all-cause mortality despite an increased risk of gastrointestinal bleeding, supporting its continued use in selected elderly patients.

HLHS不同亚型及心室-冠状动脉连接对预后的影响：Fetal Heart Society多中心研究新发现

Cardiology Clinical Updates Pediatrics

Impact of Subtypes and Ventriculocoronary Connections on Hypoplastic Left Heart Syndrome Outcomes: Insights from the Fetal Heart Society Multicenter Study

By MedXY 11/04/2026

This multicenter study reveals that among HLHS subtypes, mitral stenosis and aortic atresia with ventriculocoronary connections have the poorest transplant-free survival, highlighting the prognostic importance of prenatal and postnatal VCC assessment.

绝经后慢性肾脏病女性的心血管风险预测：来自 Women’s Health Initiative 的研究启示

Cardiology Clinical Updates Nephrology

Assessing Cardiovascular Risk Prediction Models in Postmenopausal Women With Chronic Kidney Disease: Insights from the Women’s Health Initiative

By MedXY 11/03/2026

Cardiovascular risk prediction models show limited accuracy in postmenopausal women with chronic kidney disease, often underestimating risk, highlighting the need for improved tools in this high-risk population.